CVE-2019-15931

Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.
Configurations

Configuration 1 (hide)

cpe:2.3:a:intesync:solismed:3.3:sp1:*:*:*:*:*:*

History

21 Nov 2024, 04:29

Type Values Removed Values Added
References () https://bishopfox.com - Third Party Advisory () https://bishopfox.com - Third Party Advisory
References () https://know.bishopfox.com/advisories/solismed-critical - Exploit, Third Party Advisory () https://know.bishopfox.com/advisories/solismed-critical - Exploit, Third Party Advisory
References () https://www.bishopfox.com/blog/news-category/advisories/ - Third Party Advisory () https://www.bishopfox.com/blog/news-category/advisories/ - Third Party Advisory
References () https://www.solismed.com/ - Product () https://www.solismed.com/ - Product

Information

Published : 2019-12-12 14:15

Updated : 2024-11-21 04:29


NVD link : CVE-2019-15931

Mitre link : CVE-2019-15931

CVE.ORG link : CVE-2019-15931


JSON object : View

Products Affected

intesync

  • solismed
CWE
CWE-22

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')